Email - Cancer drug shows promise for treating Alzheimer's

Donate

Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.

24/7 Helpline: 800.272.3900

Cancer drug shows promise for treating Alzheimer’s

The cancer drug sargramostim may improve memory and thinking in people living with mild-to-moderate Alzheimer’s disease, according to a small pilot study published in Alzheimer's & Dementia: Translational Research & Clinical Interventions. While experts caution the research is preliminary, participants showed a reversal of brain damage associated with Alzheimer’s, as well as improved memory and thinking ability. The Alzheimer’s Association is supporting the study through the Part the Cloud grant-funding program.

People living with dementia may need to hang up the keys

The decision to give up driving — or to ask another person to give it up — is never easy. An article in the latest issue of ALZ magazine examines how research shows that even slight changes in the brain can greatly impair a person’s ability to drive safely.

Help fight Alzheimer's

Give Now

Get Involved

Your Local Community

Find a chapter here

Middle stages of Alzheimer’s present challenges

The middle stages of Alzheimer's are typically the longest and can last for many years. We have resources to help caregivers and people living with dementia navigate challenges as the disease progresses.

More Resources:

Stages of Alzheimer's

Behaviors

Coping Strategies

Care Training


My Preferences:
Unsubscribe To stop receiving our weekly e-newsletter, simply unsubscribe.		Subscribe Was this e-newsletter forwarded to you? Subscribe to get it weekly.